Akèy › Nefwòz lipoyid › Michigan
Etid klinik pou Nefwòz lipoyid nan Michigan
5 etid pou Nefwòz lipoyid ap chèche patisipan nan sit nan Michigan.
Vil nan Michigan
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University of Michigan Health System - Ann Arbor- Site Number : 8400010, Ann Arbor
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702Nephrotic Syndrome Study Network
- CS Mott Children's Hospital, University of Michigan, Ann Arbor
- University of Michigan Medical Center, Ann Arbor
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- C.S. Mott Children's Hospital, Ann Arbor
Ap rekriteFaz 2
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
- University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Apr 29, 2026 · NCT05650619Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
- University of Michigan, Ann Arbor
Ap rekriteEtid obsèvasyon
Laj 2 ak plis · Tout sèks · Mizajou Dec 22, 2025 · NCT05505500Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.